维普中文期刊产品整合服务
20篇 您的检索式:作者名="Cheung FY"
    题名 作者 年代 出处 被引量
1Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33:implications for allergic inflammation显示文摘The novel interleukin(IL)-1 family cytokine IL-33 has been shown to activate T helper 2(Th2)lymphocytes,mast cells and basophils to produce an array of proinflammatory cytokines,as well as to mediate blood eosinophilia,IgE secretion and hypertrophy of airway epithelium in mice.In the present study,we characterized the activation of human eosinophils by IL-33,and investigated the underlying intracellular signaling mechanisms.IL-33 markedly enhanced eosinophil survival and upregulated cell surface expression of the adhesion molecule intercellular adhesion molecule(ICAM)-1 on eosinophils,but it suppressed that of ICAM-3 and L-selectin.In addition,IL-33 mediates significant release of the proinflammatory cytokine IL-6 and the chemokines CXCL8 and CCL2.We found that IL33-mediated enhancement of survival,induction of adhesion molecules,and release of cytokines and chemokines were differentially regulated by activation of the nuclear factor(NF)-KB,p38 mitogen-activated protein kinase(MAPK)and extracellular signal-regulated kinase(ERK)pathways.Furthermore,we compared the above IL-33 activities with two structurally and functionally related cytokines,IL-1 B and IL-18.IL-1β,but not IL-18,markedly upregulated cell surface expression of ICAM-1.IL-1βand IL-18 also significantly enhanced eosinophil survival,and induced the release of IL-6 and chemokines CXCL8 and CCL2 via the activation of the NF-κB,p38 MAPK and ERK pathways.Synergistic efects on the release of IL-6 were also observed in combined treatment withIL-1B,IL-18 and IL-33.Taken together,our findings provide insight into IL-33-mediated activation of eosinophils via differential intracellular signaling cascades in the immunopathogenesis of allergic inflammation.Joyce YS Chow Chun K Wong Phyllis FY Cheung Christopher WK Lam 2010Cellular & Molecular Immunology2010,7,1:22
2A population-based analysis of inci-dence,mortality,and stage-specific survival of cervical cancer patients inHong Kong:1997-2006显示文摘Cheung FY Mang OWK Law SC 2011Hong Kong Med J2011,17,2:1
3Survivinbiology and potential as a therapeutic target in oncology显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,6,10:1
4Survivin- biology and potential as a therapeutic target in oncology显示文摘Cheung CH Huang CC Tsai FY 2013Onto Targets Ther2013,6,:1
5A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin ( SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group study显示文摘Yau TC Cheung FY Lee F 2013J Clin Oncol2013,,:1
6Survivin-biology and potential as a therapeutic target in oncology显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,16,6:1
7Survivin-biology and potential as a therapeutic target in oncology 显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,6,:1
8Applications of exogenous mesenchymal stem cells and low intensity pulsed ultrasound enhance fracture healing in rat model 显示文摘Cheung WH Chin WC Wei FY 2013Ultrasound Med Biol2013,39,:1
9Bilateral substantia nigra and pyramidal tract changes following experimental intracerebral hemorrhage:an MR diffusion tensor imaging study显示文摘Fan SJ Lee FY Cheung MM 2013NMR in Biomedicine2013,26,9:1
10Survivin-biology and potential as a therapeutic target in oncology 显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,6,:1
11Survivin-biology and potential as a therapeutic target in oncology 显示文摘Cheung CH Huang CC Tsai FY 2013Onco TargetsTher2013,6,:1
12Survivin-biology and potential as a therapeutic target in oncology显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,6,:1
13Transformational leadership,leader support,and employee creativity显示文摘Cheung M FY Wong CS 0,,07:1
14Mechanisms of the vasorelaxant effect of Danshen (Salvia mihiorrhiza) in rat knee joints显示文摘Lam FY Ng SCW Cheung JHY 2006J Ethnopharmacol2006,1114,1:1
15Phase Ⅱ trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma显示文摘Yau T Chan P Cheung FY 2009European Journal of Cancer2009,7,3:1
16A population-based analysis of incidence,mortality, aud stage-specific survival of cervical cancer patients in Hong Kong:1997-2006显示文摘Cheung FY Mang OW Law SC 2011Hong Kong Med J2011,2,17:1
17A population-based analysis of incidence,mortality, and stage-specific survival of cervical cancer patients in Hong Kong:1997-2006显示文摘Cheung FY Mang OW Law SC 2011Hong Kong Med J2011,2,17:1
18Amelioration of experimental colitis by Astragalus membranaeeus thmulgh anti--oxidation and inhibition of adhesion molecuh synthesis 显示文摘Ko JK Lain FY Cheung AP 2005World J Gastroen- tero12005,11,37:1
19Survivinbiology and potential as a therapeutic target in oncology显示文摘Cheung CH Huang CC Tsai FY 2013Onco Targets Ther2013,6,:1
20A population-based analysis of incidence,mortality and stage-specific survival of cervical cancer patients in Hong Kong: 1997-2006显示文摘Cheung FY Mang OW Law SC 2011Hong Kong Med J2011,2,17:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费